aminocaproic acid has been researched along with Thrombopenia in 30 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in people with haematological disorders." | 8.93 | Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. ( Brunskill, SJ; Desborough, M; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, SJ, 2016) |
| "To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders." | 8.89 | Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. ( Brunskill, SJ; Doree, C; Estcourt, LJ; Murphy, MF; Stanworth, S; Trivella, M; Wardrop, D, 2013) |
| "Aminocaproic acid is frequently used in patients with hematologic malignancy that present with thrombocytopenia with or without hemorrhage." | 7.88 | Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies. ( Elefritz, JL; Juhl, RC; Li, J; Roddy, JVF; Wang, TF, 2018) |
| "Epsilon aminocaproic acid (EACA) is an antifibrinolytic drug that has been used to control hemorrhage by stabilizing the thrombus." | 7.73 | Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. ( Jin, T; Kalaycio, M; Kalmadi, S; Lowe, C; Tiu, R, 2006) |
| "To report a case of rhabdomyolysis associated with epsilon-aminocaproic acid (epsilon-ACA)." | 7.69 | Rhabdomyolysis induced by epsilon-aminocaproic acid. ( Rubinger, M; Seymour, BD, 1997) |
| "To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in people with haematological disorders." | 4.93 | Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. ( Brunskill, SJ; Desborough, M; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, SJ, 2016) |
| "To determine the efficacy and safety of antifibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders." | 4.89 | Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. ( Brunskill, SJ; Doree, C; Estcourt, LJ; Murphy, MF; Stanworth, S; Trivella, M; Wardrop, D, 2013) |
| "Aminocaproic acid is frequently used in patients with hematologic malignancy that present with thrombocytopenia with or without hemorrhage." | 3.88 | Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies. ( Elefritz, JL; Juhl, RC; Li, J; Roddy, JVF; Wang, TF, 2018) |
| "The antifibrinolytic aminocaproic acid is widely used in surgical settings to prevent blood loss and decrease transfusion requirements, and small observational studies have suggested that aminocaproic acid may be useful in the setting of malignancy-related bleeding." | 3.83 | Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. ( Drucker, A; Dzik, W; Li, A; Marshall, A, 2016) |
| "Epsilon aminocaproic acid (EACA) is an antifibrinolytic drug that has been used to control hemorrhage by stabilizing the thrombus." | 3.73 | Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. ( Jin, T; Kalaycio, M; Kalmadi, S; Lowe, C; Tiu, R, 2006) |
| "To report a case of rhabdomyolysis associated with epsilon-aminocaproic acid (epsilon-ACA)." | 3.69 | Rhabdomyolysis induced by epsilon-aminocaproic acid. ( Rubinger, M; Seymour, BD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (50.00) | 18.7374 |
| 1990's | 7 (23.33) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 7 (23.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Twohig, P | 1 |
| Rivington, J | 1 |
| Juhl, RC | 1 |
| Roddy, JVF | 1 |
| Wang, TF | 1 |
| Li, J | 1 |
| Elefritz, JL | 1 |
| Shakir, AK | 1 |
| Yu, Z | 1 |
| Altaf, MA | 1 |
| Wardrop, D | 1 |
| Estcourt, LJ | 2 |
| Brunskill, SJ | 2 |
| Doree, C | 2 |
| Trivella, M | 1 |
| Stanworth, S | 1 |
| Murphy, MF | 2 |
| Antun, AG | 1 |
| Gleason, S | 1 |
| Arellano, M | 1 |
| Langston, AA | 1 |
| McLemore, ML | 1 |
| Gaddh, M | 1 |
| el Rassi, F | 1 |
| Bernal-Mizrachi, L | 1 |
| Galipeau, J | 1 |
| Heffner, LT | 1 |
| Winton, EF | 1 |
| Khoury, HJ | 1 |
| Marshall, A | 1 |
| Li, A | 1 |
| Drucker, A | 1 |
| Dzik, W | 1 |
| Desborough, M | 1 |
| Hopewell, S | 1 |
| Stanworth, SJ | 1 |
| FIEHRER, A | 1 |
| CATTAN, A | 1 |
| SCHWARZENBERG, L | 1 |
| SCHNEIDER, M | 1 |
| AMIEL, JL | 1 |
| MATHE, G | 1 |
| GROSSI, CE | 1 |
| ROUSSELOT, LM | 1 |
| PANKE, WF | 1 |
| CROIZAT, P | 1 |
| REVOL, L | 1 |
| SHIMIZU, M | 1 |
| HAYASHI, H | 1 |
| UIHLEIN, A | 1 |
| OWEN, CA | 1 |
| COOPER, T | 1 |
| THOMPSON, JH | 1 |
| MANDELLI, F | 1 |
| DERIU, L | 1 |
| OMODEI-ZORINI, C | 1 |
| SHARP, AA | 1 |
| SVENNINGSEN, NW | 1 |
| Kalmadi, S | 1 |
| Tiu, R | 1 |
| Lowe, C | 1 |
| Jin, T | 1 |
| Kalaycio, M | 1 |
| Vranovská, J | 1 |
| Pospísil, J | 1 |
| Benson, K | 1 |
| Fields, K | 1 |
| Hiemenz, J | 1 |
| Zorsky, P | 1 |
| Ballester, O | 1 |
| Perkins, J | 1 |
| Elfenbein, G | 1 |
| Seymour, BD | 1 |
| Rubinger, M | 1 |
| Chakrabarti, S | 1 |
| Varma, S | 1 |
| Singh, S | 1 |
| Kumari, S | 1 |
| Fernández-Liesa, JI | 1 |
| Adame, M | 1 |
| Muñoz, C | 1 |
| Mendieta, JM | 1 |
| Panadero, A | 1 |
| Calderón, R | 1 |
| Sistino, JJ | 1 |
| Richards, C | 1 |
| Peng, TC | 1 |
| Kickler, TS | 1 |
| Bell, WR | 1 |
| Haller, E | 1 |
| Randall, J | 1 |
| Taylor, K | 1 |
| Poon, MC | 1 |
| Kloiber, R | 1 |
| Birdsell, DC | 1 |
| Molina, M | 1 |
| Ortega, G | 1 |
| Pérez Gracia, A | 1 |
| Bermudo, J | 1 |
| Ortel, TL | 1 |
| Onorato, JJ | 1 |
| Bedrosian, CL | 1 |
| Kaufman, RE | 1 |
| Gallardo, RL | 1 |
| Gardner, FH | 1 |
| Garewal, HS | 1 |
| Durie, BG | 1 |
4 reviews available for aminocaproic acid and Thrombopenia
| Article | Year |
|---|---|
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhag | 2013 |
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhag | 2016 |
PATHOLOGICAL FIBRINOLYSIS.
Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Blood Coagulation Disorders; Blood Group Incompat | 1964 |
The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Topics: Aminocaproic Acid; Blood Platelets; Bone Marrow Transplantation; Hemorrhage; Humans; Neoplasms; Plat | 1993 |
26 other studies available for aminocaproic acid and Thrombopenia
| Article | Year |
|---|---|
Platelet Count of Zero: A Curious Case of Thrombocytopenia.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Dexamethasone; Female; Herpesvirus 4, Human; Humans; Imm | 2017 |
Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies.
Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Catheterization, Central Venous; Catheters, | 2018 |
Long-term Complications and Management of Gastrointestinal Bleeding in Multifocal Lymphangioendotheliomatosis.
Topics: Adrenal Cortex Hormones; Aminocaproic Acid; Gastrointestinal Hemorrhage; Humans; Infant; Lymphangiom | 2019 |
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolyti | 2013 |
Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Female; Hematologic | 2016 |
[SEVERE HEMORRHAGIC PURPURA IN AN 89-YEAR-OLD MAN. SPECTACULAR CURE BY INTRAVENOUS INJECTIONS OF EPSILON-AMINOCAPROIC ACID].
Topics: Aminocaproates; Aminocaproic Acid; Geriatrics; Humans; Injections, Intravenous; Male; Purpura; Purpu | 1963 |
[TRIAL TREATMENT BY EPSILON-AMINOCAPROIC ACID OF PATIENTS WITH HEMORRHAGIC SYNDROMES, ESPECIALLY SYNDROMES RELATED TO A THROMBOCYTOPENIA].
Topics: Aminocaproates; Aminocaproic Acid; Anemia; Anemia, Aplastic; Humans; Leukemia; Leukemia, Lymphoid; L | 1963 |
CONTROL OF FIBRINOLYSIS DURING PORTACAVAL SHUNTS. STUDY OF PATIENTS WITH CIRRHOSIS OF THE LIVER.
Topics: Afibrinogenemia; Aminocaproates; Aminocaproic Acid; Fibrinolysis; Humans; Hypersplenism; Hypertensio | 1964 |
[APROPOS OF A COMPLEX HEMORRHAGIC SYNDROME TREATED WITH EPSILON-AMINOCAPROIC ACID].
Topics: Afibrinogenemia; Aminocaproates; Aminocaproic Acid; Fibrinolysis; Geriatrics; Humans; Hypoprothrombi | 1964 |
[HEMORRHAGIC DIATHESIS AND THE PHENOMENON OF FIBRINOLYSIS, WITH SPECIAL REFERENCE TO ITS INHIBITION].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aminocaproates; Aminocaproic Acid; Ascorbic Ac | 1964 |
BLEEDING TENDENCIES ASSOCIATED WITH PROFOUND-HYPOTHERMIA TECHNICS IN NEUROLOGIC SURGERY.
Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Disorders; Fibrinogen; Heart, Artificial; Hemos | 1964 |
[PRELIMINARY OBSERVATIONS ON THE THERAPEUTIC EFFICACY OF EPSILON-AMINO-CAPROIC ACID IN HEMORRHAGIC SYNDROMES DUE TO BLOOD PLATELET DEFECTS].
Topics: Aminocaproates; Aminocaproic Acid; Blood Platelet Disorders; Blood Platelets; Caproates; Child; Hemo | 1964 |
THROMBOCYTOPENIA AFTER RUBELLA (REPORT OF TWO CASES).
Topics: Aminocaproates; Aminocaproic Acid; Child; Drug Therapy; Epistaxis; Hematuria; Humans; Pathology; Pre | 1965 |
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Blood Transfusion; Femal | 2006 |
Changes of the activity of acid phosphatase and beta-glucuronidase in isolated platelets of whole-body irradiated rats.
Topics: Acid Phosphatase; Aminocaproic Acid; Animals; Aprotinin; Blood Platelets; Glucuronidase; Male; Rats; | 1983 |
Rhabdomyolysis induced by epsilon-aminocaproic acid.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Aspartate Aminotransferases; Creatine Kinase; Fat | 1997 |
Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia?
Topics: Adolescent; Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Humans; Middle Aged; Platelet T | 1998 |
[Common variable immunodeficiency associated with autoimmune thrombocytopenia: anesthetic management].
Topics: Adjuvants, Anesthesia; Adult; Aminocaproic Acid; Androstanols; Anesthesia, Inhalation; Anesthetics; | 1998 |
The additive effects of antifibrinolytics: dangers in the OR.
Topics: Aged; Aminocaproic Acid; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Tests; Drug Inte | 1999 |
Obstetric complications in a patient with Bernard-Soulier syndrome.
Topics: Adult; Aminocaproic Acid; Bernard-Soulier Syndrome; Female; gamma-Globulins; Humans; Immunity, Mater | 1991 |
Epsilon-aminocaproic acid myopathy.
Topics: Adult; Aminocaproic Acid; Female; Humans; Muscular Diseases; Thrombocytopenia | 1990 |
Epsilon-aminocaproic acid in the reversal of consumptive coagulopathy with platelet sequestration in a vascular malformation of Klippel-Trenaunay syndrome.
Topics: Adolescent; Aminocaproates; Aminocaproic Acid; Angiomatosis; Disseminated Intravascular Coagulation; | 1989 |
[The Kasabach-Merrit syndrome treated with aminocaproic acid].
Topics: Adult; Aminocaproates; Aminocaproic Acid; Female; Hemangioma; Humans; Mediastinal Neoplasms; Syndrom | 1989 |
Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome.
Topics: Adult; Aminocaproic Acid; Anemia, Hemolytic; Antifibrinolytic Agents; Arm; Blood Cell Count; Blood T | 1988 |
Aminocaproic acid for bleeding in thrombocytopenic patients.
Topics: Aminocaproates; Aminocaproic Acid; Hemorrhage; Humans; Thrombocytopenia | 1985 |
Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients.
Topics: Adult; Aminocaproates; Aminocaproic Acid; Antineoplastic Agents; Female; Fibrinolysis; Hemorrhage; H | 1985 |